Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Public ClinicalTrials.gov record NCT00330863. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Study identification
- NCT ID
- NCT00330863
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Northwell Health
- Other
- Enrollment
- 357 participants
Conditions and interventions
Conditions
Interventions
- Risperidone microspheres Drug
- Risperidone Drug
- Olanzapine Drug
- Quetiapine Drug
- Ziprasidone Drug
- Aripiprazole Drug
- Paliperidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Dec 31, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Jul 9, 2018
2006 – 2011
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles | Los Angeles | California | 91344 | — |
| Medical College of Georgia, Department of Psychiatry | Augusta | Georgia | 30912-3800 | — |
| University of Iowa College of Medicine, Psychiatry Research | Iowa City | Iowa | 52242 | — |
| Harvard Medical School -- Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Harvard Medical School -- Dr. John C. Corrigan Community Mental Health Center | Fall River | Massachusetts | 02720 | — |
| Creighton University | Omaha | Nebraska | 68131 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| The Zucker Hillside Hospital | Glen Oaks | New York | 11004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00330863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00330863 live on ClinicalTrials.gov.